NDC 0395-9108

Calaclear

Pramoxine Hydrochloride And Zinc Acetate

Calaclear is a Topical Lotion in the Human Otc Drug category. It is labeled and distributed by Humco Holding Group, Inc.. The primary component is Pramoxine Hydrochloride; Zinc Acetate.

Product ID0395-9108_99c4ee8a-1c66-eb0d-e053-2a95a90a40d0
NDC0395-9108
Product TypeHuman Otc Drug
Proprietary NameCalaclear
Generic NamePramoxine Hydrochloride And Zinc Acetate
Dosage FormLotion
Route of AdministrationTOPICAL
Marketing Start Date1998-03-25
Marketing CategoryOTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
Application Numberpart347
Labeler NameHumco Holding Group, Inc.
Substance NamePRAMOXINE HYDROCHLORIDE; ZINC ACETATE
Active Ingredient Strength10 mg/mL; mg/mL
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0395-9108-96

177 mL in 1 BOTTLE, PLASTIC (0395-9108-96)
Marketing Start Date1998-03-25
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0395-9108-96 [00395910896]

Calaclear LOTION
Marketing CategoryOTC monograph final
Application Numberpart347
Product TypeHUMAN OTC DRUG
Marketing Start Date1998-03-25

Drug Details

Active Ingredients

IngredientStrength
PRAMOXINE HYDROCHLORIDE10 mg/mL

NDC Crossover Matching brand name "Calaclear" or generic name "Pramoxine Hydrochloride And Zinc Acetate"

NDCBrand NameGeneric Name
0395-9108CalaclearPramoxine Hydrochloride and Zinc Acetate
49035-402CalaclearPramoxine Hydrochloride and Zinc Acetate
82645-923CalaclearPramoxine Hydrochloride and Zinc Acetate
0187-5466Caladryl ClearPRAMOXINE HYDROCHLORIDE and ZINC ACETATE
24385-439Caldyphen ClearPramoxine Hydrochloride and Zinc acetate
69842-400CVS Itch ReliefPramoxine Hydrochloride and Zinc Acetate
0395-0400Humco CalaclearPramoxine Hydrochloride and Zinc Acetate

Trademark Results [Calaclear]

Mark Image

Registration | Serial
Company
Trademark
Application Date
CALACLEAR
CALACLEAR
76665040 not registered Dead/Abandoned
HUMCO HOLDING GROUP, INC.
2006-08-23

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.